State Board of Administration of Florida Retirement System’s Spero Therapeutics SPRO Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio SPRO Stock Details SPRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,007	Closed	-$96K	–	2402
2022 Q1	$96K	Hold	11,007	–	–	﹤0.01%	2276
2021 Q4	$176K	Hold	11,007	–	–	﹤0.01%	2244
2021 Q3	$203K	Hold	11,007	–	–	﹤0.01%	2256
2021 Q2	$154K	Buy	+11,007	New	+$154K	﹤0.01%	2321

Other funds holding SPRO

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Board of Administration of Florida Retirement System's SPRO Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Spero Therapeutics (SPRO) in Q2 2022, closing a stake of 11,007 shares — an estimated $96K sold.

State Board of Administration of Florida Retirement System first reported a position in SPRO in Q2 2021 and held it in 4 quarters. The position peaked at $203K in Q3 2021. 79 funds tracked by Wall St. Rank hold SPRO as of Q2 2022.

State Board of Administration of Florida Retirement System reported no remaining Spero Therapeutics position as of Q2 2022 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 11,007 Spero Therapeutics shares in Q2 2022, an estimated $96K.
State Board of Administration of Florida Retirement System first reported a position in Spero Therapeutics in Q2 2021 and held it in 4 quarters.
State Board of Administration of Florida Retirement System's Spero Therapeutics position peaked at $203K in Q3 2021.
79 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.